MODIFICATION OF THE EFFECT OF TAMOXIFEN, CISPLATIN, DTIC, AND INTERFERON-ALPHA-2B ON HUMAN-MELANOMA CELLS IN CULTURE BY A MIXTURE OF VITAMINS

被引:74
作者
PRASAD, KN [1 ]
HERNANDEZ, C [1 ]
EDWARDSPRASAD, J [1 ]
NELSON, J [1 ]
BORUS, T [1 ]
ROBINSON, WA [1 ]
机构
[1] UNIV COLORADO,HLTH SCI CTR,SCH MED,DEPT MED,DENVER,CO 80262
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 1994年 / 22卷 / 03期
关键词
D O I
10.1080/01635589409514349
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effect of a mixture of vitamins in modifying the efficacy of commonly used drugs in the treatment of human melanoma has not been studied. Vitamin C and d-alpha-tocopheryl succinate (alpha-TS) alone reduced the growth of human melanoma (SK-30) cells in culture, whereas beta-carotene (BC), 13-cis-retinoic acid (RA), or sodium selenite alone was ineffective. RA caused morphological changes, as evidenced by flattening of cells and formation of short cytoplasmic processes. A mixture of four vitamins (vitamin C, BC, alpha-TS, and RA) was more effective in reducing growth of human melanoma cells than a mixture of three vitamins. The growth-inhibitory effect of cis-platin, decarbazine, tamoxifen, and recombinant interferon-alpha 2b was enhanced by vitamin C alone, a mixture of three vitamins (BC, alpha-TS, and RA), and a mixture of four vitamins (vitamin C, BC, alpha-TS, and RA) that contained 50 mu g/ml of vitamin C These data show that a mixture of three oi four vitamins can enhance the growth-inhibitory effect of currently used chemotherapeutic agents on human melanoma cells.
引用
收藏
页码:233 / 245
页数:13
相关论文
共 39 条
[1]   SYNERGISTIC KILLING OF EHRLICH ASCITES CARCINOMA CELLS BY ASCORBATE AND 3-AMINO-1,2,4-TRIAZOLE [J].
BENADE, L ;
HOWARD, T ;
BURK, D .
ONCOLOGY, 1969, 23 (01) :33-&
[2]   VITAMIN-C PREFERENTIAL TOXICITY FOR MALIGNANT-MELANOMA CELLS [J].
BRAM, S ;
FROUSSARD, P ;
GUICHARD, M ;
JASMIN, C ;
AUGERY, Y ;
SINOUSSIBARRE, F ;
WRAY, W .
NATURE, 1980, 284 (5757) :629-631
[3]   SUPPLEMENTAL ASCORBATE IN SUPPORTIVE TREATMENT OF CANCER - PROLONGATION OF SURVIVAL TIMES IN TERMINAL HUMAN CANCER .1. [J].
CAMERON, E ;
PAULING, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (10) :3685-3689
[4]  
CAMERON E, 1979, CANCER RES, V39, P663
[5]   RRR-ALPHA-TOCOPHERYL SUCCINATE INHIBITS PROLIFERATION AND ENHANCES SECRETION OF TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) BY HUMAN BREAST-CANCER CELLS [J].
CHARPENTIER, A ;
GROVES, S ;
SIMMONSMENCHACA, M ;
TURLEY, J ;
ZHAO, BH ;
SANDERS, BG ;
KLINE, K .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1993, 19 (03) :225-239
[6]  
ERSHOFF BH, 1960, P SOC EXP BIOL MED, V104, P274
[7]  
FUJITA K, 1982, CANCER RES, V42, P309
[8]  
GEETHA A, 1990, Indian Journal of Physiology and Pharmacology, V34, P94
[9]   INCREASED THERAPEUTIC EFFICACY OF ZIDOVUDINE IN COMBINATION WITH VITAMIN-E [J].
GOGU, SR ;
BECKMAN, BS ;
RANGAN, SRS ;
AGRAWAL, KC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (01) :401-407
[10]  
HAZUKA MB, 1990, J AM COLL NUTR, V9, P143